Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Chih-Cheng Lai and Cheng-Yi Wang.
Chih-Cheng Lai
Connection Strength
1.395
Cheng-Yi Wang
  1. Clinical efficacy and safety of remdesivir in patients with COVID-19: a systematic review and network meta-analysis of randomized controlled trials. J Antimicrob Chemother. 2021 07 15; 76(8):1962-1968.
    View in: PubMed
    Score: 0.239
  2. In vitro diagnostics of coronavirus disease 2019: Technologies and application. J Microbiol Immunol Infect. 2021 Apr; 54(2):164-174.
    View in: PubMed
    Score: 0.221
  3. Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents? J Microbiol Immunol Infect. 2020 Aug; 53(4):505-512.
    View in: PubMed
    Score: 0.221
  4. Global coronavirus disease 2019: What has daily cumulative index taught us? Int J Antimicrob Agents. 2020 Jun; 55(6):106001.
    View in: PubMed
    Score: 0.220
  5. Global epidemiology of coronavirus disease 2019 (COVID-19): disease incidence, daily cumulative index, mortality, and their association with country healthcare resources and economic status. Int J Antimicrob Agents. 2020 Apr; 55(4):105946.
    View in: PubMed
    Score: 0.218
  6. Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths. J Microbiol Immunol Infect. 2020 Jun; 53(3):404-412.
    View in: PubMed
    Score: 0.218
  7. The effect of tocilizumab on COVID-19 patient mortality: A systematic review and meta-analysis of randomized controlled trials. Int Immunopharmacol. 2021 Jul; 96:107602.
    View in: PubMed
    Score: 0.059
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.